Diabetes drug tested for lung clot inflammation

This study looked at whether semaglutide, a medicine used for diabetes, changes certain blood markers related to inflammation in people who recently had a pulmonary embolism (a blood clot in the lung). 18 adults with acute pulmonary embolism took semaglutide, and researchers measured their blood levels of a marker called CD147 before and after 4 weeks of treatment. The goal was to understand how the drug might affect the body's response to the clot, not to treat the clot itself.